| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 58,834,000 | 47.30% | ||
| 2 | Catabasis Pharmaceuticals Inc | 2,857,667 | 22,661,000 | 18.22% | ||
| 3 | TRANSENTERIX INC | 7,546,692 | 18,716,000 | 15.05% | ||
| 4 | OCULAR THERAPEUTIX INC | 1,932,607 | 18,109,000 | 14.56% | ||
| 5 | RAPTOR PHARMACEUTICAL CORP | 888,132 | 4,618,000 | 3.71% | ||
| 6 | LOMBARD MEDICAL INC | 1,077,499 | 1,455,000 | 1.17% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-015098, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
